Daily Briefing – May 29: Dell detonates the AI infrastructure trade, oil falls on U.S.-Iran/Hormuz deal hopes, PCE stays hot, GDP slips, Okta stabilizes identity security, and apparel retail shows consumer weakness
The May 29 briefing is now led by a very clear equity signal: the AI infrastructure trade is not dead, and Dell just gave it one of the strongest hard-data confirmations of the season. Dell surged in premarket trading after raising its fiscal 2027 revenue outlook to roughly $165-$169 billion, lifting its AI-server revenue expectation to about $60 billion and reporting a massive first-quarter revenue jump driven by Nvidia-powered systems and data-center demand. That makes Dell the headline stock, but the read-through stretches across the physical AI buildout: Super Micro, HPE, Nvidia, Marvell, Broadcom, Micron, Vertiv, GE Vernova and the broader data-center power/cooling chain. Macro is also helping risk appetite, but in a more fragile way. Reuters reported that global stocks gained and oil dropped as markets reacted to hopes for a U.S.-Iran ceasefire extension and possible progress toward reopening the Strait of Hormuz, though the deal was still not fully finalized in the reporting window. That oil relief is important because April PCE inflation is still elevated, with BEA data showing headline PCE at 3.8% year over year and core PCE at 3.3%. Q1 GDP was revised down to 1.6%, keeping the slower-growth/sticky-inflation debate alive. Under the surface, the market remains selective: Okta is helping cybersecurity after a solid report and an AI-agent identity-security angle, while SentinelOne is under pressure after soft guidance and a workforce reduction plan. Costco still points to resilience in membership/value retail, but Gap and American Eagle are warning that apparel demand remains weak. The tape is constructive, but the message is not “buy everything.” It is “pay for visible AI demand, clean guidance and real catalysts.”
- DELL— Dell is today’s cleanest single-stock winner after raising fiscal 2027 revenue guidance to roughly $165-$169 billion and lifting its AI-server revenue expectation to about $60 billion, up from the prior $50 billion viewAI Servers
- DELL / NVDA— The Dell move is a major confirmation for Nvidia-powered AI systems. The key trader read-through is that enterprise and hyperscale AI infrastructure demand remains large enough to change full-year numbersNvidia Read
- SMCI / HPE— Super Micro and Hewlett Packard Enterprise remain direct sympathy names as investors reassess server demand, rack-scale systems, enterprise AI deployment and the profitability of physical AI infrastructureServer Basket
- VRT / GEV— Dell’s report also supports the power, cooling and data-center infrastructure trade. If AI server revenue keeps scaling, the market will keep watching electricity, thermal management and grid-capacity beneficiariesPower / Cooling
- MRVL / AVGO / MU— Marvell’s recent data-center strength, Broadcom’s AI networking/custom-silicon exposure and Micron’s AI memory angle all get a cleaner backdrop when Dell confirms strong server demandAI Supply Chain
- OKTA— Okta is the positive cybersecurity read today. Revenue and adjusted EPS beat expectations, and management’s focus on AI agents and non-human identity gives the stock a cleaner AI-linked security angleIdentity Security
- S— SentinelOne is the negative software/security read. The company issued a soft quarterly outlook and announced a plan to cut about 8% of its workforce while redirecting investment toward AI, data and cloudCybersecurity
- COST— Costco remains a useful consumer-quality read. Sales and membership trends look resilient, but the slightly soft EPS reaction keeps the market focused on margins and whether value retail can keep outperformingConsumer
- GAP / AEO— Gap and American Eagle are today’s weaker consumer-discretionary signals after apparel-demand concerns. The read-through is not that the whole consumer is broken, but that fashion/apparel remains selective and fragileApparel
- ABBV— AbbVie has a confirmed FDA item this week with Decnupaz approved for adult patients with blastic plasmacytoid dendritic cell neoplasm, an ultra-rare and aggressive blood cancerFDA / Oncology
- SPY / QQQ / SOXX— The index read-through remains AI-positive, but the rally still needs oil relief and contained yields. If rates rise again after hot PCE, leadership may stay narrow around the clearest AI infrastructure winnersIndex Tape
- Oil relief— Reuters reported oil lower and global stocks firmer as markets reacted to hopes for a U.S.-Iran ceasefire extension and possible progress toward reopening the Strait of HormuzOil / Geo
- Hormuz risk not gone— The proposed U.S.-Iran/Hormuz framework was still not fully finalized in the reporting window. That means crude can reverse quickly if approval, implementation or shipping-restriction headlines disappointGeo Risk
- PCE remains hot— BEA data showed April headline PCE inflation at 3.8% year over year and core PCE at 3.3%. The monthly core number was manageable, but the annual inflation picture remains too high for real comfortInflation
- GDP revision— Q1 GDP was revised down to 1.6% annualized from the earlier 2.0% estimate. That keeps the slower-growth/sticky-inflation discussion alive even as AI earnings support the equity tapeGrowth
- Rates are the judge— AI hardware can lead, but the broader growth trade still needs stable Treasury yields. If the 2-year and 10-year yields rise, software, biotech and small caps may lag even on a green-index dayRates
- Dollar and yields— The dollar and Treasury curve remain the cleanest confirmation tools for the macro reaction. Lower oil helps, but sticky PCE limits how dovish the market can getMacro FX
- Consumer split— Costco resilience versus Gap/American Eagle weakness shows that the U.S. consumer story is segmented. Membership/value models look stronger than discretionary apparelConsumer
- Software dispersion— Okta and SentinelOne keep the software message selective. AI language is not enough: investors are paying for clean execution, beat-and-raise setups and credible monetizationSoftware
- Record-high fragility— With major indexes near record territory, positive headlines can keep momentum alive, but bad inflation, oil or guidance surprises can trigger fast multiple compressionTape
- Replimune Group (Nasdaq: $REPL): RP1 Gets A Third FDA Opening After The Second CRL
- ASCO 2026 Investor Calendar: 25 Key Oncology Presentations, Dates, Times and Webcasts to Track
- Three Biotech Data Presentations to Watch: Precision BioSciences, Lipocine and Citius Oncology $DTIL $LPCN $CTOR
- Artiva Biotherapeutics, Inc. (Nasdaq: $ARTV): EULAR, AlloNK and the Institutional Read-Through Ahead of the Next Catalyst
- Biotech Catalyst Watch: Phase 2 IgAN Start, CRB-701 Cancer Data And Cullinan Autoimmune Updates $JBIO $CRBP $CGEM
- Healthcare Catalyst Watch: RenovoRx ASCO Data, Axsome AUVELITY Updates, Olema-Bayer Trial Deal $RNXT $AXSM $OLMA
- Biotech Catalyst Watch: Dyne Files BLA, NervGen Reports Neural Recovery Data, BriaCell Gets DSMB Green Light $DYN $NGEN $BCTX
- Karyopharm’s ASCO Moment: Can a Mixed Phase 3 Still Become a Myelofibrosis Story? $KPTI
- Three Near-Term Biotech Catalysts To Watch: Nuvalent, Legend Biotech and Zenas BioPharma $NUVL $LEGN $ZBIO
- Artelo Biosciences (Nasdaq: $ARTL) — May 2026 Deep Dive: FABP5 Pain Catalyst, ART27.13 Optionality, Balance-Sheet Reset and Dilution Reality
- Natera, Inc. (Nasdaq: $NTRA): A Full Deep Dive Into the cfDNA Platform, Signatera Momentum, FDA CDx Validation, Fetal Focus, Prospera and the Next Catalyst Stack
- Immuneering Corporation (Nasdaq: $IMRX): ASCO Survival Update Turns Atebimetinib Into a High-Stakes Pancreatic Cancer Story
Run-Up Biotech Masterclass
Learn how to read biotech catalysts, trial results and FDA decisions with a practical framework.
OpenBiotech Catalyst Calendar
Track FDA events, clinical readouts and biotech catalysts with a practical event-driven tool.
Open ArchiveBrowse the Blog & Archive
Explore articles, biotech deep dives, market notes, reports and archived sector content.
Open Reality CheckBiotech Trading Without the Fairy Tales
A grounded piece on risk, catalysts, dilution, volatility and biotech trading reality.
Open 2026 WatchlistThe New Era – Space, Defense & AI
A thematic watchlist built around military spending, strategic technology and AI-linked trends.
Open BriefingSPACE AI DEFENCE
A thematic briefing at the intersection of defense, space infrastructure and AI.
Open Top ListTop 10 Defense-Tech Stocks to Watch
A focused list built around defense technology, drones and strategic systems.
Open Top ListTop 5 U.S. Airlines Watchlist
A practical watchlist for pricing power, fuel sensitivity, travel demand and macro tone.
Open Top ListTop 5 Cruise Lines Watchlist
A leisure-focused list centered on major cruise operators and pricing-driven sentiment.
OpenTry ChartsWatcher free, then unlock 10% OFF with SAVE10
ChartsWatcher is a real-time scanner for momentum traders: fast movers, unusual volume and sector rotations — so you can focus on the few tickers that matter right now, instead of watching hundreds of charts.
Start with the free version. When you upgrade, use SAVE10 to get 10% OFF your first paid period.
No credit card required to start. Apply SAVE10 when upgrading.
One platform. All your brokers.
Medved Trader connects multiple brokers in one workspace, with professional charts, hotkeys and fast execution — without changing your broker accounts.
A single cockpit for positions, Level II and multi-broker order routing, built for active day and swing traders.
Multi-broker workflow + customizable layouts in one platform.












